246 related articles for article (PubMed ID: 30891959)
21. Expansion of the complex genotypic and phenotypic spectrum of FGFR2-associated neurocutaneous syndromes.
Schmidt J; Kaulfuß S; Ott H; Gaubert M; Reintjes N; Bremmer F; Dreha-Kulaczewski S; Stroebel P; Yigit G; Wollnik B
Hum Genet; 2024 Feb; 143(2):159-168. PubMed ID: 38265560
[TBL] [Abstract][Full Text] [Related]
22. Expending the Phenotypic Spectrum of Encephalocraniocutaneous Lipomatosis: About a Prenatal Case With Complete Autopsy.
Cattin J; Formet J; Sartelet H; Lenoir M; Riethmuller D; Collardeau-Frachon S
Pediatr Dev Pathol; 2022; 25(2):180-185. PubMed ID: 34547955
[TBL] [Abstract][Full Text] [Related]
23. A Patient With Schimmelpenning Syndrome and Mosaic KRAS Mutation.
Mitchell BJ; Rogers GF; Wood BC
J Craniofac Surg; 2019 Jan; 30(1):184-185. PubMed ID: 30394973
[TBL] [Abstract][Full Text] [Related]
24. Mosaic RASopathies concept: different skin lesions, same systemic manifestations?
Morren MA; Fodstad H; Brems H; Bedoni N; Guenova E; Jacot-Guillarmod M; Busiah K; Giuliano F; Gilliet M; Atallah I
J Med Genet; 2024 Apr; 61(5):411-419. PubMed ID: 38290824
[TBL] [Abstract][Full Text] [Related]
25. Expanding mutational spectrum of HRAS by a patient with Schimmelpenning-Feuerstein-Mims syndrome.
Luo Q; Zhang Q; Shen J; Guan W; Li M; Zhang J; Tan Z
J Dermatol; 2021 Aug; 48(8):1273-1276. PubMed ID: 34109654
[TBL] [Abstract][Full Text] [Related]
26. RASopathies.
Jafry M; Sidbury R
Clin Dermatol; 2020; 38(4):455-461. PubMed ID: 32972603
[TBL] [Abstract][Full Text] [Related]
27. Encephalocraniocutaneous Lipomatosis.
Bavle A; Shah R; Gross N; Gavula T; Ruiz-Elizalde A; Wierenga K; McNall-Knapp R
J Pediatr Hematol Oncol; 2018 Oct; 40(7):553-554. PubMed ID: 29683947
[TBL] [Abstract][Full Text] [Related]
28. Papular nevus spilus syndrome: old and new aspects of a mosaic RASopathy.
Torchia D; Happle R
Eur J Dermatol; 2019 Feb; 29(1):2-5. PubMed ID: 30827948
[TBL] [Abstract][Full Text] [Related]
29. Encephalocraniocutaneous Lipomatosis Without Ocular Malformations.
Radić Nišević J; Prpić I; Antulov R; Sasso A; Holjar Erlić I
Pediatr Neurol; 2016 Jul; 60():71-4. PubMed ID: 27131628
[TBL] [Abstract][Full Text] [Related]
30. Somatic BRAF c.1799T>A p.V600E Mosaicism syndrome characterized by a linear syringocystadenoma papilliferum, anaplastic astrocytoma, and ocular abnormalities.
Watanabe Y; Shido K; Niihori T; Niizuma H; Katata Y; Iizuka C; Oba D; Moriya K; Saito-Nanjo Y; Onuma M; Rikiishi T; Sasahara Y; Watanabe M; Aiba S; Saito R; Sonoda Y; Tominaga T; Aoki Y; Kure S
Am J Med Genet A; 2016 Jan; 170A(1):189-94. PubMed ID: 26360803
[TBL] [Abstract][Full Text] [Related]
31. Pigmented trichoblastoma developed in a sebaceous nevus: HRAS mutation as a common molecular driver.
Saraggi D; Salmaso R; Valentini E; Munari G; Vindigni V; Rugge M; Fassan M; Cerroni L
Pathol Res Pract; 2017 Jul; 213(7):860-862. PubMed ID: 28554764
[TBL] [Abstract][Full Text] [Related]
32. Identification of a recurrent mosaic
Green TE; MacGregor D; Carden SM; Harris RV; Hewitt CA; Berkovic SF; Penington AJ; Scheffer IE; Hildebrand MS
Cold Spring Harb Mol Case Stud; 2021 Dec; 7(6):. PubMed ID: 34649968
[TBL] [Abstract][Full Text] [Related]
33. Phacomatosis pigmentokeratotica is caused by a postzygotic HRAS mutation in a multipotent progenitor cell.
Groesser L; Herschberger E; Sagrera A; Shwayder T; Flux K; Ehmann L; Wollenberg A; Torrelo A; Bagazgoitia L; Diaz-Ley B; Tinschert S; Oschlies I; Singer S; Mickler M; Toll A; Landthaler M; Real FX; Hafner C
J Invest Dermatol; 2013 Aug; 133(8):1998-2003. PubMed ID: 23337891
[TBL] [Abstract][Full Text] [Related]
34. Identification of KRAS mutation in a patient with linear nevus sebaceous syndrome: a case report.
Pan C; Zhou X; Hong A; Fang F; Wang Y
BMC Med Genomics; 2020 Dec; 13(1):188. PubMed ID: 33308209
[TBL] [Abstract][Full Text] [Related]
35. Is Schimmelpenning Syndrome Associated with Intracranial Tumors? A Case Report.
Chiang MC; McDowell MM; Weaver K; Broniscer A; Greene S
Pediatr Neurosurg; 2019; 54(3):201-206. PubMed ID: 30879010
[TBL] [Abstract][Full Text] [Related]
36. Encephalocraniocutaneous lipomatosis.
Levy ML; Massey C
Handb Clin Neurol; 2015; 132():265-9. PubMed ID: 26564086
[TBL] [Abstract][Full Text] [Related]
37. HRAS-related epidermal nevus syndromes: Expansion of the spectrum with first branchial arch defects.
Beyens A; Lietaer C; Claes K; De Baere E; Goeteyn M; Lerut B; Syryn H; Vanakker O; Van der Meulen J; Vanwalleghem L; Callewaert B
Clin Genet; 2023 Jun; 103(6):709-713. PubMed ID: 36896710
[TBL] [Abstract][Full Text] [Related]
38. Patient with recurrent mosaic KRAS variant: Rare oculoectodermal syndrome with severe neurologic phenotype.
Ververi A; Laidou S; Chatzidimitriou A; Gidaris D; Mataftsi A; Kozeis N; Fidani L; Zafeiriou DI
J Dermatol; 2022 Oct; 49(10):e381-e382. PubMed ID: 35593416
[No Abstract] [Full Text] [Related]
39. Encephalocraniocutaneous lipomatosis (ECCL): neuroradiological findings in three patients and a new association with fibrous dysplasia.
Delfino LN; Fariello G; Quattrocchi CC; Aiello C; Menchini L; Devito R; Zama M; Claps D; Vigevano F; Longo D
Am J Med Genet A; 2011 Jul; 155A(7):1690-6. PubMed ID: 21626669
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
